Improvement of Blood Pressure Control in a Hypertension Clinic in Japan: A 15-Year Follow-Up Study
- 4 November 2009
- journal article
- Published by Taylor & Francis in Clinical and Experimental Hypertension
- Vol. 31 (7) , 553-559
Abstract
Many guidelines recommended strict blood pressure (BP) control to prevent cardiovascular events. However, BP control in a substantial majority of hypertensives remains to be insufficient. We have determined the trends of BP control of the same patients during 15 years in a hypertension clinic. One hundred three patients (age 32–91, mean 68 ± 11 years in 2006), who were followed at our hypertension clinic between 1991–2006, were retrospectively investigated. We compared the clinical characteristics of the patients in 2006 to those in 1991, 1996, and 2001, using the averaged BP determined at two occasions of each year for our analysis. The average BP decreased from 144 ± 17/87 ± 10 mmHg to 132 ± 12/75 ± 10 mmHg (p < 0.01) during the 15 years between 1991 and 2006. When good BP control was defined as < 140/90 mmHg, the rate of patients with good BP control increased from 35% in 1991 to 45% in 1996, to 54% in 2001 (p < 0.01 vs. 1991), and to 72% in 2006 (p < 0.01 vs. 1991). The number of anti-hypertensive drugs used in 2006 significantly increased compared to those in 1991, 1996, and 2001. More specifically, the use of diuretics and α-blockers increased significantly during this period. Results suggest that BP control improved in the 15 years studied, and the increased use of the anti-hypertensive drugs, as well as the increased awareness of the importance of strict BP control, seems to have contributed to improve the BP control.Keywords
This publication has 29 references indexed in Scilit:
- Compliance With Joint National Committee 7 Guidelines in Hypertension Management in a Teaching InstitutionAmerican Journal of Medical Quality, 2007
- 2007 Guidelines for the Management of Arterial HypertensionJournal Of Hypertension, 2007
- The Future of Antihypertensive TreatmentAmerican Journal of Therapeutics, 2007
- Metabolic Side Effects and Cardiovascular Events of Diuretics: Should a Diuretic Remain the First Choice Therapy in Hypertension Treatment? The Case of YesClinical and Experimental Hypertension, 2007
- Usefulness of the .ALPHA.1-Blocker Doxazosin as a Third-Line Antihypertensive DrugHypertension Research, 2007
- Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)Hypertension Research, 2006
- Hypertension Treatment and Control in Five European Countries, Canada, and the United StatesHypertension, 2004
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy.Hypertension, 1992
- Control of coronary heart disease risk factors with doxazosin as monotherapy and in combination therapyAmerican Heart Journal, 1988